Peter C Gøtzsche1. 1. Nordic Cochrane Centre, H:S Rigshospitalet, DK-2100 Copenhagen Ø, Denmark,. pcg@cochrane.dk
Abstract
OBJECTIVE: To compare the distribution of P values in abstracts of randomised controlled trials with that in observational studies, and to check P values between 0.04 and 0.06. DESIGN: Cross sectional study of all 260 abstracts in PubMed of articles published in 2003 that contained "relative risk" or "odds ratio" and reported results from a randomised trial, and random samples of 130 abstracts from cohort studies and 130 from case-control studies. P values were noted or calculated if unreported. MAIN OUTCOME MEASURES: Prevalence of significant P values in abstracts and distribution of P values between 0.04 and 0.06. RESULTS: The first result in the abstract was statistically significant in 70% of the trials, 84% of cohort studies, and 84% of case-control studies. Although many of these results were derived from subgroup or secondary analyses, or biased selection of results, they were presented without reservations in 98% of the trials. P values were more extreme in observational studies (P < 0.001) and in cohort studies than in case-control studies (P = 0.04). The distribution of P values around P = 0.05 was extremely skewed. Only five trials had 0.05 < or = P < 0.06, whereas 29 trials had 0.04 < or = P < 0.05. I could check the calculations for 27 of these trials. One of four non-significant results was significant. Four of the 23 significant results were wrong, five were doubtful, and four could be discussed. Nine cohort studies and eight case-control studies reported P values between 0.04 and 0.06, but in all 17 cases P < 0.05. Because the analyses had been adjusted for confounders, these results could not be checked. CONCLUSIONS: Significant results in abstracts are common but should generally be disbelieved.
OBJECTIVE: To compare the distribution of P values in abstracts of randomised controlled trials with that in observational studies, and to check P values between 0.04 and 0.06. DESIGN: Cross sectional study of all 260 abstracts in PubMed of articles published in 2003 that contained "relative risk" or "odds ratio" and reported results from a randomised trial, and random samples of 130 abstracts from cohort studies and 130 from case-control studies. P values were noted or calculated if unreported. MAIN OUTCOME MEASURES: Prevalence of significant P values in abstracts and distribution of P values between 0.04 and 0.06. RESULTS: The first result in the abstract was statistically significant in 70% of the trials, 84% of cohort studies, and 84% of case-control studies. Although many of these results were derived from subgroup or secondary analyses, or biased selection of results, they were presented without reservations in 98% of the trials. P values were more extreme in observational studies (P < 0.001) and in cohort studies than in case-control studies (P = 0.04). The distribution of P values around P = 0.05 was extremely skewed. Only five trials had 0.05 < or = P < 0.06, whereas 29 trials had 0.04 < or = P < 0.05. I could check the calculations for 27 of these trials. One of four non-significant results was significant. Four of the 23 significant results were wrong, five were doubtful, and four could be discussed. Nine cohort studies and eight case-control studies reported P values between 0.04 and 0.06, but in all 17 cases P < 0.05. Because the analyses had been adjusted for confounders, these results could not be checked. CONCLUSIONS: Significant results in abstracts are common but should generally be disbelieved.
Authors: Stuart J Pocock; Timothy J Collier; Kimberley J Dandreo; Bianca L de Stavola; Marlene B Goldman; Leslie A Kalish; Linda E Kasten; Valerie A McCormack Journal: BMJ Date: 2004-10-06
Authors: Ana Macura; Iosief Abraha; Jamie Kirkham; Gian Franco Gensini; Lorenzo Moja; Alfonso Iorio Journal: Intern Emerg Med Date: 2010-03-19 Impact factor: 3.397
Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman Journal: BMJ Date: 2010-03-23
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: BMJ Date: 2009-07-21
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: PLoS Med Date: 2009-07-21 Impact factor: 11.069